Increased availability ensures that more individuals can benefit from this safe and effective approach to weight management
Novo Nordisk), which are glucagon-like peptide-1 receptor agonists (GLP-1Ra), have been sanctioned for prolonged weight management in people living with obesity (PwO)
As the body adapts to improved blood sugar control, reduced appetite, and lower calorie intake, temporary changes in brain energy supply can affect focus, often described as Mounjaro brain fog, especially during the initial phase or after dose increases
By week 12, the trajectory of glucose improvement typically becomes clear
Custom dosing of estrogen, progesterone, testosterone, and DHEA tailored to your lab results
A GLP-1 agonist that helps with weight loss might be covered when prescribed for a different approved use